Typhoid fever physical examination: Difference between revisions
No edit summary |
Aysha Aslam (talk | contribs) No edit summary |
||
(2 intermediate revisions by 2 users not shown) | |||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Typhoid fever}} | {{Typhoid fever}} | ||
{{CMG}}; {{AE}} {{ | {{CMG}}; {{AE}} {{AAA}} | ||
== Overview == | == Overview == | ||
Line 114: | Line 114: | ||
[[Category:Gastroenterology]] | [[Category:Gastroenterology]] | ||
[[Category:FinalQCRequired]] | [[Category:FinalQCRequired]] | ||
[[Category:Emergency mdicine]] | |||
[[Category:Disease]] | |||
[[Category:Up-To-Date]] | |||
[[Category:Infectious disease]] |
Latest revision as of 02:41, 18 July 2021
Typhoid fever Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Typhoid fever physical examination On the Web |
American Roentgen Ray Society Images of Typhoid fever physical examination |
Risk calculators and risk factors for Typhoid fever physical examination |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aysha Aslam, M.B.B.S[2]
Overview
Common physical examination findings of typhoid fever include stepwise increase in temperature, bradycardia,[1] abdominal tenderness, and hepatosplenomegaly initially. In the third week of illness the patient may present with signs of complications.[2][3] Physical examination findings are dependent upon the timing of presentation.
Physical examination
Common physical examination findings of typhoid fever are described in the following table:[2][3]
Organ System | First Week | Second Week[4] | Third Week |
---|---|---|---|
General Appearance |
|
|
|
Vital signs |
|
|
|
Skin |
|
|
|
HEENT |
|
|
|
CV |
| ||
Pulmonary |
|
|
|
Abdomen |
|
|
|
Neurological |
|
|
|
Musculoskeletal |
|
|
|
References
- ↑ 1.0 1.1 Ostergaard L, Huniche B, Andersen PL (1996). "Relative bradycardia in infectious diseases". J Infect. 33 (3): 185–91. PMID 8945708.
- ↑ 2.0 2.1 Parry CM, Hien TT, Dougan G, White NJ, Farrar JJ (2002). "Typhoid fever". N Engl J Med. 347 (22): 1770–82. doi:10.1056/NEJMra020201. PMID 12456854.
- ↑ 3.0 3.1 Azmatullah A, Qamar FN, Thaver D, Zaidi AK, Bhutta ZA (2015). "Systematic review of the global epidemiology, clinical and laboratory profile of enteric fever". J Glob Health. 5 (2): 020407. doi:10.7189/jogh.05.020407. PMC 4672836. PMID 26649174.
- ↑ 4.0 4.1 Neil KP, Sodha SV, Lukwago L, O-Tipo S, Mikoleit M, Simington SD; et al. (2012). "A large outbreak of typhoid fever associated with a high rate of intestinal perforation in Kasese District, Uganda, 2008-2009". Clin Infect Dis. 54 (8): 1091–9. doi:10.1093/cid/cis025. PMID 22357703.
- ↑ 5.0 5.1 5.2 Hoffman SL, Punjabi NH, Kumala S, Moechtar MA, Pulungsih SP, Rivai AR; et al. (1984). "Reduction of mortality in chloramphenicol-treated severe typhoid fever by high-dose dexamethasone". N Engl J Med. 310 (2): 82–8. doi:10.1056/NEJM198401123100203. PMID 6361558.
- ↑ Akbayram S, Parlak M, Dogan M, Karasin G, Akbayram HT, Karaman KT (2016). "Clinical and Haematological Manifestations of Typhoid Fever in Children in Eastern Turkey". West Indian Med J. 65 (1). doi:10.7727/wimj.2014.354. PMID 26901611.
- ↑ Villablanca P, Mohananey D, Meier G, Yap JE, Chouksey S, Abegunde AT (2015). "Salmonella Berta myocarditis: Case report and systematic review of non-typhoid Salmonella myocarditis". World J Cardiol. 7 (12): 931–7. doi:10.4330/wjc.v7.i12.931. PMC 4691820. PMID 26730299.
- ↑ Lutterloh E, Likaka A, Sejvar J, Manda R, Naiene J, Monroe SS; et al. (2012). "Multidrug-resistant typhoid fever with neurologic findings on the Malawi-Mozambique border". Clin Infect Dis. 54 (8): 1100–6. doi:10.1093/cid/cis012. PMID 22357702.